David Lambeth

Corporate Officer/Principal presso Emory University School of Medicine

Consumer Services

Health Technology

Posizioni attive di David Lambeth

Società	Posizione	Inizio	Fine
Emory University School of Medicine	Corporate Officer/Principal	01/01/1980	-

Società	Posizione	Inizio	Fine
Calliditas Therapeutics Suisse SA Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland.	Fondatore	01/01/2006	-

Duke University

Doctorate Degree

Distribuzione geografica

Stati Uniti	3
Svizzera	2

Posizioni

Founder	1
Doctorate Degree	1
Corporate Officer/Principal	1

Settori

Consumer Services	3
Health Technology	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	1
Calliditas Therapeutics Suisse SA Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland.	Health Technology

Aziende private

Health Technology